美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
70860-781-01	70860-781	HUMAN PRESCRIPTION DRUG	Glycopyrrolate	glycopyrrolate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230131	N/A	ANDA	ANDA210083	Athenex Pharmaceutical Division, LLC.	GLYCOPYRROLATE	.2 mg/mL	25 VIAL in 1 CARTON (70860-781-01) / 1 mL in 1 VIAL (70860-781-41)
70860-781-02	70860-781	HUMAN PRESCRIPTION DRUG	Glycopyrrolate	glycopyrrolate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230131	N/A	ANDA	ANDA210083	Athenex Pharmaceutical Division, LLC.	GLYCOPYRROLATE	.2 mg/mL	25 VIAL in 1 CARTON (70860-781-02) / 2 mL in 1 VIAL (70860-781-42)
70860-781-05	70860-781	HUMAN PRESCRIPTION DRUG	Glycopyrrolate	glycopyrrolate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230131	N/A	ANDA	ANDA210083	Athenex Pharmaceutical Division, LLC.	GLYCOPYRROLATE	.2 mg/mL	25 VIAL in 1 CARTON (70860-781-05) / 5 mL in 1 VIAL (70860-781-43)
70860-781-20	70860-781	HUMAN PRESCRIPTION DRUG	Glycopyrrolate	glycopyrrolate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20230131	N/A	ANDA	ANDA210083	Athenex Pharmaceutical Division, LLC.	GLYCOPYRROLATE	.2 mg/mL	10 VIAL in 1 CARTON (70860-781-20) / 20 mL in 1 VIAL (70860-781-44)
25021-796-01	25021-796	HUMAN PRESCRIPTION DRUG	Glycopyrrolate	Glycopyrrolate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20241015	N/A	ANDA	ANDA210083	Sagent Pharmaceuticals	GLYCOPYRROLATE	.2 mg/mL	10 VIAL in 1 CARTON (25021-796-01) / 1 mL in 1 VIAL
25021-796-02	25021-796	HUMAN PRESCRIPTION DRUG	Glycopyrrolate	Glycopyrrolate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20241115	N/A	ANDA	ANDA210083	Sagent Pharmaceuticals	GLYCOPYRROLATE	.2 mg/mL	10 VIAL in 1 CARTON (25021-796-02) / 2 mL in 1 VIAL
25021-796-05	25021-796	HUMAN PRESCRIPTION DRUG	Glycopyrrolate	Glycopyrrolate	INJECTION, SOLUTION	INTRAMUSCULAR; INTRAVENOUS	20241115	N/A	ANDA	ANDA210083	Sagent Pharmaceuticals	GLYCOPYRROLATE	.2 mg/mL	10 VIAL in 1 CARTON (25021-796-05) / 5 mL in 1 VIAL